Adimmune Corp
TWSE:4142
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Adimmune Corp
Accounts Receivables
Adimmune Corp
Accounts Receivables Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Accounts Receivables | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Adimmune Corp
TWSE:4142
|
Accounts Receivables
NT$438.5m
|
CAGR 3-Years
-30%
|
CAGR 5-Years
0%
|
CAGR 10-Years
17%
|
|
|
GenMont Biotech Inc
TWSE:3164
|
Accounts Receivables
NT$42.4m
|
CAGR 3-Years
-1%
|
CAGR 5-Years
4%
|
CAGR 10-Years
-4%
|
|
|
E
|
Energenesis Biomedical Co Ltd
TWSE:6657
|
Accounts Receivables
NT$1.4m
|
CAGR 3-Years
-2%
|
CAGR 5-Years
5%
|
CAGR 10-Years
N/A
|
|
|
Pell Bio Med Technology Co Ltd
TWSE:6949
|
Accounts Receivables
NT$5.1m
|
CAGR 3-Years
-6%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Kim Forest Enterprise Co Ltd
TWSE:6645
|
Accounts Receivables
NT$112.3m
|
CAGR 3-Years
-10%
|
CAGR 5-Years
5%
|
CAGR 10-Years
N/A
|
|
Adimmune Corp
Glance View
ADIMMUNE CORPORATION is a Taiwan-based company principally engaged in the research and development, processing, manufacture and trading of influenza vaccine products and non-flu vaccine products. The Company's products include Japanese encephalitis vaccines, tetanus vaccines, influenza vaccines, H1N1 influenza vaccines and tuberculin. The vaccine products are applied in the prevention of various infectious viruses. The tuberculin is applied in tuberculin purified protein derivative (PPD) test. The Company distributes its products within domestic market and to overseas markets, including other markets in Asia, Europe and Africa.
See Also
What is Adimmune Corp's Accounts Receivables?
Accounts Receivables
438.5m
TWD
Based on the financial report for Sep 30, 2025, Adimmune Corp's Accounts Receivables amounts to 438.5m TWD.
What is Adimmune Corp's Accounts Receivables growth rate?
Accounts Receivables CAGR 10Y
17%
Over the last year, the Accounts Receivables growth was -37%. The average annual Accounts Receivables growth rates for Adimmune Corp have been -30% over the past three years , and 17% over the past ten years .
